NOVAVAX EXEC SAYS TOO EARLY TO SAY IF OMICRON-SPEFCIFIC VACCINE IS THE RIGHT APPROACH OR IF ORIGINAL COVID-19 VACCINE GENERATES A SUFFICIENTLY BROAD PROTECTIVE RESPONSE TO USE AS A BOOST- JPM CONF